Madrigal Pharmaceuticals Common Stock share price logo

Madrigal Pharmaceuticals Common Stock

NASDAQ: MDGL

Large Cap

$501.19

+1.43

(+0.29%)

as on

Madrigal Pharmaceuticals Common Stock Stock Performance

as on June 17, 2026 at 2:15 pm IST

  • Day's Low

    Day's High

    $493.00
    $507.75
    downward going graph

    1.63%

    Downside

    1.31%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $275.00
    $615.00
    downward going graph

    45.13%

    Downside

    22.71%

    Upside

    downward going graph

Madrigal Pharmaceuticals Common Stock share price movements today

Previous Close
$499.76
Open
$505.34
Volume
299.1K
Day's Low - High
$493.00 - $507.75
52 Week Low - High
$275.00 - $615.00

Madrigal Pharmaceuticals Common Stock Historical Returns

1 Month Return
-4.3 %
3 Month Return
+ 13.09 %
1 Year Return
+ 79.25 %
3 Year Return
+ 105.33 %
5 Year Return
+ 376.96 %

Madrigal Pharmaceuticals Common Stock Stock Fundamentals & Key Indicators

Check Madrigal Pharmaceuticals Common Stock market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$11.5B

EPS (TTM)

-6.5233

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-312.0M

Revenue (TTM)

1.1B

Profit Margin

-27.32%

Return On Equity TTM

-49.35%

Madrigal Pharmaceuticals Common Stock vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Madrigal Pharmaceuticals Common Stock with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
BUY$11.5B376.96%NA-27.32%NA
BUY$38.4B63.66%72.4912.55%NA
BUY$114.3B140.59%26.7335.51%NA
BUY$64.5B14.69%15.0229.65%0.58%

Stock Returns calculator for Madrigal Pharmaceuticals Common Stock Stock including INR - Dollar returns

The Madrigal Pharmaceuticals Common Stock stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Madrigal Pharmaceuticals Common Stock investment value today

Current value as on today

₹1,97,428

Returns

₹97,428

(+97.43%)

Returns from Madrigal Pharmaceuticals Common Stock Stock

₹79,253 (+79.25%)

Dollar Impact

₹18,176 (+18.18%)

Analyst Recommendation on Madrigal Pharmaceuticals Common Stock Stock

Based on 21 analysts

BUY

80.95%

Buy

14.29%

Hold

4.76%

Sell

Based on 21 analysts, 80.95% of analysts recommend a 'BUY' rating for Madrigal Pharmaceuticals Common Stock. Average target price of $678.71

Madrigal Pharmaceuticals Common Stock Share Price Target

Get share price movements and forecasts by analysts on Madrigal Pharmaceuticals Common Stock.

What analysts predicted

26.16%UPSIDE

Target Price

$678.71

Current Price

$501.19

Analyzed by

21 Analysts

Target

$678.71

Madrigal Pharmaceuticals Common Stock target price $678.71, a slight upside of 26.16% compared to current price of $501.19. According to 21 analysts rating.

Indian Investors' Interest in Madrigal Pharmaceuticals Common Stock Stock

Search interest for Madrigal Pharmaceuticals Common Stock Stock has decreased by -22% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-22% versus previous 30 day period

Madrigal Pharmaceuticals Common Stock Quarterly Profit & Loss

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Total Revenue
0
-
14
62
103
137
212
287
321
311
Gross Profit
0
0
14
60
99
132
203
269
296
284
Operating Income
-117
-152
-162
-116
-66
-79
-47
-113
-59
-92
EBITDA
-108
-143
-148
-102
-55
-69
-38
-106
-49
-86
Interest Expense
3
3
3
3
3
3
3
7
8
7
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-112
-147
-151
-106
-59
-73
-42
-114
-58
-94
Income Tax Expense
0
0
-
0
-
-
-
-
-
-
Net Income
-112
-147
-151
-106
-59
-73
-42
-114
-58
-94
Net Profit Margin
-14570.65%
0.00%
-1038.20%
-172.04%
-57.51%
-53.36%
-19.87%
-39.75%
-18.24%
-30.32%

Madrigal Pharmaceuticals Common Stock Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
0
0
-
0
0
-
-
180
958
Gross Profit
0
0
0
0
0
0
0
0
173
902
Operating Income
-25
-32
-40
-94
-206
-242
-293
-380
-497
-300
EBITDA
-25
-31
-40
-94
-206
-242
-290
-360
-450
-264
Interest Expense
1
0
7
11
4
1
3
12
14
22
Depreciation
-
0
0
0
0
0
0
0
1
1
Income Before Tax
-26
-31
-32
-83
-202
-241
-295
-373
-465
-288
Income Tax Expense
0
0
7
-11
-4
0
3
-
-465
-
Net Income
-26
-31
-32
-72
-197
-241
-295
-373
-465
-288
Net Profit Margin
0.00%
-8901.14%
-16405.50%
0.00%
-903055.25%
-646009.97%
0.00%
0.00%
-258.64%
-30.08%

Madrigal Pharmaceuticals Common Stock Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Net Income
-147
-151
-106
-59
-73
-42
-114
-58
-94
Operating Cash Flow
-149
-134
-66
-104
-88
-47
79
-133
-167
Investing Cash Flow
98
-122
-202
-47
163
47
-206
27
192
Financing Cash Flow
573
134
7
19
8
1
236
8
2
Change in Cash
522
-122
-261
-132
83
2
109
-96
28

Madrigal Pharmaceuticals Common Stock Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-31
-32
-83
-202
-241
-295
-373
-465
-288
Operating Cash Flow
-22
-25
-41
-157
-183
-224
-324
-455
-189
Investing Cash Flow
-22
-380
30
159
-5
206
-502
-274
32
Financing Cash Flow
173
314
0
5
171
313
595
735
255
Change in Cash
129
-91
-10
7
-17
295
-231
5
98

Global Institutional Holdings in Madrigal Pharmaceuticals Common Stock

Funds
Holdings
State Street Corp
2.64%
Geode Capital Management, LLC
1.98%
Citadel Advisors Llc
1.97%
Amvescap Plc.
1.43%
venBio Select Advisor LLC
7.89%

Insights on Madrigal Pharmaceuticals Common Stock

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, MDGL has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, MDGL has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, MDGL stock has moved up by 6.3%

About Madrigal Pharmaceuticals Common Stock

Madrigal Pharmaceuticals, Inc., a biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States. It offers Rezdiffra, a liver-directed thyroid hormone receptor beta agonist for treating MASH. The company was founded in 2016 and is headquartered in West Conshohocken, Pennsylvania.
OrganisationMadrigal Pharmaceuticals Common Stock
HeadquartersFour Tower Bridge, West Conshohocken, PA, United States, 19428
IndustryBiotechnology
CEOMr. William J. Sibold
E-voting on sharesClick here to vote

Key Management of Madrigal Pharmaceuticals Common Stock

Name

Title

Dr. Rebecca A. Taub M.D.

Founder, Senior Scientific & Medical Advisor and Director

Dr. David Soergel M.D.

Executive VP & Chief Medical Officer

Mr. Mark Underwood

Executive Vice President of Business Planning & Operations

Ms. Rita Thakkar

Senior VP & Chief Accounting Officer

Mr. Ronald Filippo

Executive VP & Chief Information Officer

Ms. Tina E. Ventura

Chief Investor Relations Officer

Mr. William J. Sibold

CEO, President & Director

Ms. Mardi C. Dier

Executive VP & CFO

Ms. Shannon Kelley

Executive VP, Chief Legal Officer & Corporate Secretary

Ms. Carole Huntsman

Executive VP & Chief Commercial Officer

FAQs

What is Madrigal Pharmaceuticals Common Stock share price today?

Madrigal Pharmaceuticals Common Stock share price today is $501.19 as on at the close of the market. Madrigal Pharmaceuticals Common Stock share today touched a day high of $507.75 and a low of $493.

What is the 52 week high and 52 week low for Madrigal Pharmaceuticals Common Stock share?

Madrigal Pharmaceuticals Common Stock share touched a 52 week high of $615 on and a 52 week low of $275 on . Madrigal Pharmaceuticals Common Stock stock price today i.e. is closed at $501.19,which is 18.51% down from its 52 week high and 82.25% up from its 52 week low.

What is Madrigal Pharmaceuticals Common Stock's market capitalisation today?

Madrigal Pharmaceuticals Common Stock market capitalisation is $0.01T as on .

How to invest in Madrigal Pharmaceuticals Common Stock Stock (MDGL) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Madrigal Pharmaceuticals Common Stock on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Madrigal Pharmaceuticals Common Stock Shares that will get you 0.0030 shares as per Madrigal Pharmaceuticals Common Stock share price of $501.19 per share as on June 17, 2026 at 8:45 am IST.

What is the minimum amount required to buy Madrigal Pharmaceuticals Common Stock Stock (MDGL) from India?

Indian investors can start investing in Madrigal Pharmaceuticals Common Stock (MDGL) shares with as little as ₹94.55 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹945.50 in Madrigal Pharmaceuticals Common Stock stock (as per the Rupee-Dollar exchange rate as on ). Based on Madrigal Pharmaceuticals Common Stock share’s latest price of $501.19 as on June 17, 2026 at 8:45 am IST, you will get 0.0200 shares of Madrigal Pharmaceuticals Common Stock. Learn more about fractional shares .

What are the returns that Madrigal Pharmaceuticals Common Stock has given to Indian investors in the last 5 years?

Madrigal Pharmaceuticals Common Stock stock has given 376.96% share price returns and 29.26% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?